Search

29 Apr 2024: On rare occasions, a new drug being tested can have unexpected adverse effects. ... Pilot studies will be employed when first attempting growth of a new source of human immune cells.

29 Apr 2024: For breeding design we use several online resources, especially when bringing in a new strain. ... care for our strains and to identify any new and better treatments that could be utilised.

29 Apr 2024: This project will develop and test the safety and effectiveness of new vaccines against EHV induced disease. ... Comprehensive details are provided for the new owner and advice given in any areas required.

29 Apr 2024: Discoveries made on new bacterial species will be published and available to other researchers. ... We continuously consider their use and development in light of new experimental data.

29 Apr 2024: Animals will be brought in and allowed to acclimatise for a few weeks - this helps them to relax in their new surroundings, gets them used to the staff and human contact ... bones, which acts as a shock absorber), to which the new implant/therapy will be

29 Apr 2024: This could lead to development of new therapies that are more effective and cause fewer side effects to patients. ... More specifically, we expect to generate at least one new therapy and advance it to a stage that it can be investigated further in large

29 Apr 2024: activities including publications in magazines, news articles, blogs, and via twitter / social media feeds. ... We will perform pilot experiments, for e.g. to check the effectiveness of new therapies.

29 Apr 2024: New knowledge will be disseminated in. PPL number: | Granted: 17 Feb 23 | Amended: 23 Aug 23 | Expires: 17 Feb 28. ... The majority of our vaccine studies can be considered "pilot studies" as we are measuring immune responses to new vaccines.